Kinyanjui, S., Mwangi, T., Bull, P., Newbold, C., & Marsh, K. (2004). Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections.
Chicago Style (17th ed.) CitationKinyanjui, S., T. Mwangi, P. Bull, C. Newbold, and K. Marsh. Protection Against Clinical Malaria by Heterologous Immunoglobulin G Antibodies Against Malaria-infected Erythrocyte Variant Surface Antigens Requires Interaction with Asymptomatic Infections. 2004.
MLA citiranjeKinyanjui, S., et al. Protection Against Clinical Malaria by Heterologous Immunoglobulin G Antibodies Against Malaria-infected Erythrocyte Variant Surface Antigens Requires Interaction with Asymptomatic Infections. 2004.